Ukuhlaselwa kwe-allergy, okanye i- immunotherapy , ngokuqhubekayo kutholakala eUnited States njengenye indlela yokukhangela ukunyanga kwamanzi. Olu unyango lusetyenziswe ngokukhuselekileyo nangempumelelo eYurophu iminyaka emininzi kodwa aluzange ludume e-United States kude kube kutshanje.
Amaconsi e-allergies awavunywanga okwangoku yi-Food and Drug Administration, ngoko ke ithathwa njengonyango lovavanyo.
Nangona kunjalo, unikezelwa ubuncwane beengxelo zezokwelapha ezibonisa ukhuseleko kunye nokuphumelela kwe-allergies ehlaselwe unyango lwe -rhinitis ye-allergen , i -conjunctivitis ye -allergen , kunye ne- asthma ye- allergen, abaninzi be-allergists e-United States banikela le fom ye-immunotherapy.
Ngoko ke, abanye abantu banokuthi banikwe ukhetho phakathi kwama-downer and downs . Nazi ezinye iingqinisiso ezithile phakathi kweendlela ezimbini ezahlukeneyo zokuqwalasela xa usenza isigqibo.
Ziza kuthathwa njani iibhotshi okanye amahlumelo?
Iibhotshi zilawulwa kwiofisi yee-allergy kanye kanye kwiiveki ezi-3 ukuya kwezi-6; emva kokuphindwe kabini inyanga iminyaka eyi-3 ukuya kwe-5 iyonke. Amaconsi alawulwa ngokwawo rhoqo ngosuku phantsi kweelwimi ekhaya, ngokuqhelekileyo ukuphela kweminyaka emi-3 ukuya kweyonke.
Kuthatha ixesha elide ukuqala ukusebenza?
Izibhengezo ze-allergies zihlala ziqala ukusebenza kwiinyanga ezi-3 ukuya kwezi-6, kodwa ngokuqinisekileyo zingangeenyanga ezili-12, kuxhomekeke kwindlela edlalwa ngayo. Ezinye iingxelo zibonisa ukuba ukuhla kwamanzi kuqala ukusebenza kwiiveki eziyi-8 zonyango; ezinye izifundo zibonisa inzuzo ithatha iminyaka eyi-1 ukuya kweyesi-2 ukuba ivele.
Yiyiphi inyango ekhuselekileyo?
Izibhengezo ze-allergies zikhuselekile kodwa kufuneka zinikezwe phantsi kolawulo lwonyango. Izigulane ezifumana izibhengezo zokungabikho kwezifo kufuneka zibekwe iliso kwiminqaku engama-20 ukuya kwe-30, xa kunikezwa ithuba elincinci lokuphendulela . Amanxuwa e-allergies aphephile kakhulu-akukho ukuphazamiseka okubulalayo kuye kwabikwa, nangona ukuphendula okunzima kuye kwenzeka.
Amanxuwa e-allergies angakwazi ukulawulwa ngokwawo ekhaya ngaphandle kokulawulwa ngonyango ngqo.
Liliphi iTyhutyana elisebenza kakuhle?
Uphando lubonisa ukuba ukukhwabanisa kwamanye amazwe kusebenza ngokuphindaphindiweyo kabini kunye nokuhla kwamanzi.
Ziyindleko Kangakanani?
Uninzi lweenkampani ze-inshorensi zonyango zifikelela kwinani elibalulekileyo leendleko zokungabikho komzimba, nangona iintlawulo zentsebenziswano kunye neentlawulo zonyaka zisebenza. Ekubeni ama-drops of allergies awavunyelwanga yi-FDA, abaxutywanga yi-inshurensi. Nangona kunjalo, iindleko zokuhlaselwa kwamanzi azinokuthi zihluthwe ngokulondolozwa ngokungagqibekanga ixesha kunye neendleko zokuhamba kwiofisi yonyango ukufumana izibhengezo zokungahambi.
Ingaba kukho naziphi na ii-Immunotherapy ezizodwa ezivunyelweyo eUnited States?
Ewe, kukho iipilisi ezi-3 ezichaseneyo zokufumana izilwanyana ezivunyelwe ukonyango lwe-rhinitis kunye ne-conjunctivitis ye-allergen e-United States. Ezi macwecwe, ezibizwa ngokuthi i-Oralair, i-Grastek, ne-Ragwitek, ziboniswa kuphela ngenxa yezifo ezibangelwa yintyatyambo yamanzi okanye i- ragweed pollen .
Imithombo:
> Cox LS, Linnemann DL, uNolte H, Weldon D, Finegold I, uNelson HS. I-Immunotherapy yeeNkcazo: Uhlolo oluPhezulu. J Allergy Clin Immunol. 2006; 117: 1021-35.
> IPotter PC. Uhlaziyo kwi-Subunication Immunotherapy. Ann Annistry Asthma Immunol. 2006; 96: S22-5.
> I-American Academy ye-Allergy, i-Asthma ne-Immunology. I-Allergen Immunotherapy Iinkqubo zeParameters. Ann Annistry Asthma Immunol. 2003; 90: S1-40.